{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T02:00:31Z","timestamp":1785376831935,"version":"3.55.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI100720"],"award-info":[{"award-number":["R01AI100720"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI145570"],"award-info":[{"award-number":["R01AI145570"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R56AI125128"],"award-info":[{"award-number":["R56AI125128"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-70119-6","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T10:34:40Z","timestamp":1772879680000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Recurrent and novel evolutionary pathways drive in vitro HIV-1 lenacapavir resistance with diverse phenotypic consequences"],"prefix":"10.1038","volume":"17","author":[{"given":"Luke L.","family":"Orris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Adnan","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raajita","family":"Bose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4482-2378","authenticated-orcid":false,"given":"Masahiro","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,7]]},"reference":[{"key":"70119_CR1","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/s41586-020-2443-1","volume":"584","author":"JO Link","year":"2020","unstructured":"Link, J. O. et al. Clinical targeting of HIV capsid protein with a long-acting small molecule. Nature 584, 614\u2013618 (2020).","journal-title":"Nature"},{"key":"70119_CR2","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1126\/science.abb4808","volume":"370","author":"SM Bester","year":"2020","unstructured":"Bester, S. M. et al. Structural and mechanistic bases for a potent HIV-1 capsid inhibitor. Science 370, 360\u2013364 (2020).","journal-title":"Science"},{"key":"70119_CR3","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1056\/NEJMoa2115542","volume":"386","author":"S Segal-Maurer","year":"2022","unstructured":"Segal-Maurer, S. et al. Capsid inhibition with lenacapavir in multidrug-resistant HIV-1 infection. N. Engl. J. Med. 386, 1793\u20131803 (2022).","journal-title":"N. Engl. J. Med."},{"key":"70119_CR4","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1056\/NEJMoa2407001","volume":"391","author":"LG Bekker","year":"2024","unstructured":"Bekker, L. G. et al. Twice-yearly lenacapavir or daily F\/TAF for HIV prevention in cisgender women. N. Engl. J. Med. 391, 1179\u20131192 (2024).","journal-title":"N. Engl. J. Med."},{"key":"70119_CR5","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1056\/NEJMoa2411858","volume":"392","author":"CF Kelley","year":"2025","unstructured":"Kelley, C. F. et al. Twice-yearly lenacapavir for HIV prevention in men and gender-diverse persons. N. Engl. J. Med. 392, 1261\u20131276 (2025).","journal-title":"N. Engl. J. Med."},{"key":"70119_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.854974","volume":"13","author":"P Troyano-Hernaez","year":"2022","unstructured":"Troyano-Hernaez, P., Reinosa, R. & Holguin, A. HIV capsid protein genetic diversity across HIV-1 variants and impact on new capsid-inhibitor lenacapavir. Front. Microbiol. 13, 854974 (2022).","journal-title":"Front. Microbiol."},{"key":"70119_CR7","doi-asserted-by":"publisher","unstructured":"Tao, K. et al. HIV-1 group M capsid amino acid variability: implications for sequence quality control of genotypic resistance testing. Viruses 15, https:\/\/doi.org\/10.3390\/v15040992 (2023).","DOI":"10.3390\/v15040992"},{"key":"70119_CR8","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1038\/s41591-019-0560-x","volume":"25","author":"SR Yant","year":"2019","unstructured":"Yant, S. R. et al. A highly potent long-acting small-molecule HIV-1 capsid inhibitor with efficacy in a humanized mouse model. Nat. Med. 25, 1377\u20131384 (2019).","journal-title":"Nat. Med."},{"key":"70119_CR9","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1093\/jac\/dkab503","volume":"77","author":"N Margot","year":"2022","unstructured":"Margot, N. et al. Phenotypic resistance to lenacapavir and monotherapy efficacy in a proof-of-concept clinical study. J. Antimicrob. Chemother. 77, 989\u2013995 (2022).","journal-title":"J. Antimicrob. Chemother."},{"key":"70119_CR10","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1093\/infdis\/jiac364","volume":"226","author":"NA Margot","year":"2022","unstructured":"Margot, N. A. et al. Resistance analyses in highly treatment-experienced people with human immunodeficiency virus (HIV) treated with the novel capsid HIV inhibitor lenacapavir. J. Infect. Dis. 226, 1985\u20131991 (2022).","journal-title":"J. Infect. Dis."},{"key":"70119_CR11","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1093\/jac\/dkae115","volume":"79","author":"M Wirden","year":"2024","unstructured":"Wirden, M. et al. Ultra-rapid selection of the N74D capsid inhibitor resistance mutation after 3 weeks on lenacapavir. J. Antimicrob. Chemother. 79, 1706\u20131707 (2024).","journal-title":"J. Antimicrob. Chemother."},{"key":"70119_CR12","doi-asserted-by":"publisher","unstructured":"Margot, N. A. et al. Resistance analyses in heavily treatment-experienced people with HIV treated with the novel HIV capsid inhibitor lenacapavir after 2 years. J. Infect. Dis. https:\/\/doi.org\/10.1093\/infdis\/jiaf050 (2025).","DOI":"10.1093\/infdis\/jiaf050"},{"key":"70119_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.70340","volume":"97","author":"S Demirdjian","year":"2025","unstructured":"Demirdjian, S., Naik, V., Margot, N., Falkard, B. & Callebaut, C. Phenotypic characterization of replication-impaired lenacapavir-resistant HIV clinical isolates. J. Med. Virol. 97, e70340 (2025).","journal-title":"J. Med. Virol."},{"key":"70119_CR14","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1093\/jac\/dkaa060","volume":"75","author":"A-G Marcelin","year":"2020","unstructured":"Marcelin, A.-G. et al. Frequency of capsid substitutions associated with GS-6207 in vitro resistance in HIV-1 from antiretroviral-naive and -experienced patients. J. Antimicrob. Chemother. 75, 1588\u20131590 (2020).","journal-title":"J. Antimicrob. Chemother."},{"key":"70119_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-021-00577-x","volume":"18","author":"A Saito","year":"2021","unstructured":"Saito, A. & Yamashita, M. HIV-1 capsid variability: viral exploitation and evasion of capsid-binding molecules. Retrovirology 18, 32 (2021).","journal-title":"Retrovirology"},{"key":"70119_CR16","doi-asserted-by":"publisher","first-page":"e1003461","DOI":"10.1371\/journal.ppat.1003461","volume":"9","author":"SJ Rihn","year":"2013","unstructured":"Rihn, S. J. et al. Extreme genetic fragility of the HIV-1 capsid. PLoS Pathog. 9, e1003461 (2013).","journal-title":"PLoS Pathog."},{"key":"70119_CR17","doi-asserted-by":"publisher","unstructured":"Himmel, D. M. & Arnold, E. Non-nucleoside reverse transcriptase inhibitors join forces with integrase inhibitors to combat HIV. Pharmaceuticals 13, https:\/\/doi.org\/10.3390\/ph13060122 (2020).","DOI":"10.3390\/ph13060122"},{"key":"70119_CR18","doi-asserted-by":"publisher","unstructured":"Richetta, C., Tu, N. Q. & Delelis, O. Different pathways conferring integrase strand-transfer inhibitors resistance. Viruses 14, https:\/\/doi.org\/10.3390\/v14122591 (2022).","DOI":"10.3390\/v14122591"},{"key":"70119_CR19","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.antiviral.2008.06.012","volume":"80","author":"M Kobayashi","year":"2008","unstructured":"Kobayashi, M. et al. Selection of diverse and clinically relevant integrase inhibitor-resistant human immunodeficiency virus type 1 mutants. Antiviral Res. 80, 213\u2013222 (2008).","journal-title":"Antiviral Res."},{"key":"70119_CR20","doi-asserted-by":"publisher","unstructured":"Sultana, T. et al. Multiple pathways to avoid beta interferon sensitivity of HIV-1 by mutations in capsid. J. Virol. 93, https:\/\/doi.org\/10.1128\/JVI.00986-19 (2019).","DOI":"10.1128\/JVI.00986-19"},{"key":"70119_CR21","doi-asserted-by":"publisher","unstructured":"Mallery, D. L. et al. IP6 is an HIV pocket factor that prevents capsid collapse and promotes DNA synthesis. eLife 7, https:\/\/doi.org\/10.7554\/eLife.35335 (2018).","DOI":"10.7554\/eLife.35335"},{"key":"70119_CR22","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nature19098","volume":"536","author":"DA Jacques","year":"2016","unstructured":"Jacques, D. A. et al. HIV-1 uses dynamic capsid pores to import nucleotides and fuel encapsidated DNA synthesis. Nature 536, 349\u2013353 (2016).","journal-title":"Nature"},{"key":"70119_CR23","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41586-018-0396-4","volume":"560","author":"RA Dick","year":"2018","unstructured":"Dick, R. A. et al. Inositol phosphates are assembly co-factors for HIV-1. Nature 560, 509\u2013512 (2018).","journal-title":"Nature"},{"key":"70119_CR24","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01804-22","volume":"13","author":"SM Bester","year":"2022","unstructured":"Bester, S. M. et al. Structural and mechanistic bases of viral resistance to HIV-1 capsid inhibitor lenacapavir. mBio 13, e0180422 (2022).","journal-title":"mBio"},{"key":"70119_CR25","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0140-6736(25)00405-2","volume":"405","author":"V Jogiraju","year":"2025","unstructured":"Jogiraju, V. et al. Pharmacokinetics and safety of once-yearly lenacapavir: a phase 1, open-label study. Lancet 405, 1147\u20131154 (2025).","journal-title":"Lancet"},{"key":"70119_CR26","doi-asserted-by":"crossref","unstructured":"Forshey, B. M., von Schwedler, U., Sundquist, W. I. & Aiken, C. Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication. J. Virol. 76, 5667\u20135677 (2002).","DOI":"10.1128\/JVI.76.11.5667-5677.2002"},{"key":"70119_CR27","doi-asserted-by":"publisher","unstructured":"Shah, V. B. & Aiken, C. In vitro uncoating of HIV-1 cores. J. Vis. Exp. https:\/\/doi.org\/10.3791\/3384 (2011).","DOI":"10.3791\/3384"},{"key":"70119_CR28","doi-asserted-by":"publisher","unstructured":"Christensen, D. E., Ganser-Pornillos, B. K., Johnson, J. S., Pornillos, O. & Sundquist, W. I. Reconstitution and visualization of HIV-1 capsid-dependent replication and integration in vitro. Science 370, https:\/\/doi.org\/10.1126\/science.abc8420 (2020).","DOI":"10.1126\/science.abc8420"},{"key":"70119_CR29","doi-asserted-by":"publisher","unstructured":"Faysal, K. M. R. et al. Pharmacologic hyperstabilisation of the HIV-1 capsid lattice induces capsid failure. Elife 13, https:\/\/doi.org\/10.7554\/eLife.83605 (2024).","DOI":"10.7554\/eLife.83605"},{"key":"70119_CR30","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.03613-24","volume":"16","author":"L Briganti","year":"2025","unstructured":"Briganti, L. et al. Structural and mechanistic bases for resistance of the M66I capsid variant to lenacapavir. mBio 16, e0361324 (2025).","journal-title":"mBio"},{"key":"70119_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-9-30","volume":"9","author":"R Yang","year":"2012","unstructured":"Yang, R. et al. Second-site suppressors of HIV-1 capsid mutations: restoration of intracellular activities without correction of intrinsic capsid stability defects. Retrovirology 9, 30 (2012).","journal-title":"Retrovirology"},{"key":"70119_CR32","doi-asserted-by":"publisher","first-page":"e1003868","DOI":"10.1371\/journal.ppat.1003868","volume":"10","author":"MS Henning","year":"2014","unstructured":"Henning, M. S., Dubose, B. N., Burse, M. J., Aiken, C. & Yamashita, M. In vivo functions of CPSF6 for HIV-1 as revealed by HIV-1 capsid evolution in HLA-B27-positive subjects. PLoS Pathog. 10, e1003868 (2014).","journal-title":"PLoS Pathog."},{"key":"70119_CR33","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.chom.2010.02.007","volume":"7","author":"K Lee","year":"2010","unstructured":"Lee, K. et al. Flexible use of nuclear import pathways by HIV-1. Cell Host Microbe 7, 221\u2013233 (2010).","journal-title":"Cell Host Microbe"},{"key":"70119_CR34","doi-asserted-by":"publisher","first-page":"e1002896","DOI":"10.1371\/journal.ppat.1002896","volume":"8","author":"AJ Price","year":"2012","unstructured":"Price, A. J. et al. CPSF6 defines a conserved capsid interface that modulates HIV-1 replication. PLoS Pathog. 8, e1002896 (2012).","journal-title":"PLoS Pathog."},{"key":"70119_CR35","doi-asserted-by":"publisher","first-page":"6918","DOI":"10.1128\/JVI.00019-16","volume":"90","author":"A Saito","year":"2016","unstructured":"Saito, A. et al. Capsid-CPSF6 interaction is dispensable for HIV-1 replication in primary cells but is selected during virus passage in vivo. J. Virol. 90, 6918\u20136935 (2016).","journal-title":"J. Virol."},{"key":"70119_CR36","doi-asserted-by":"publisher","first-page":"e1012537","DOI":"10.1371\/journal.ppat.1012537","volume":"20","author":"A Deshpande","year":"2024","unstructured":"Deshpande, A. et al. Elasticity of the HIV-1 core facilitates nuclear entry and infection. PLoS Pathog. 20, e1012537 (2024).","journal-title":"PLoS Pathog."},{"key":"70119_CR37","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2420497122","volume":"122","author":"C Li","year":"2025","unstructured":"Li, C. et al. Lenacapavir disrupts HIV-1 core integrity while stabilizing the capsid lattice. Proc. Natl. Acad. Sci. USA. 122, e2420497122 (2025).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"70119_CR38","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01445-21","volume":"95","author":"GA Sowd","year":"2021","unstructured":"Sowd, G. A., Shi, J. & Aiken, C. HIV-1 CA inhibitors are antagonized by inositol phosphate stabilization of the viral capsid in cells. J. Virol. 95, e0144521 (2021).","journal-title":"J. Virol."},{"key":"70119_CR39","doi-asserted-by":"publisher","first-page":"e1012206","DOI":"10.1371\/journal.ppat.1012206","volume":"21","author":"TM Scott","year":"2025","unstructured":"Scott, T. M. et al. Cell-free assays reveal that the HIV-1 capsid protects reverse transcripts from cGAS immune sensing. PLoS Pathog. 21, e1012206 (2025).","journal-title":"PLoS Pathog."},{"key":"70119_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103593","volume":"25","author":"A Selyutina","year":"2022","unstructured":"Selyutina, A. et al. GS-CA1 and lenacapavir stabilize the HIV-1 core and modulate the core interaction with cellular factors. iScience 25, 103593 (2022).","journal-title":"iScience"},{"key":"70119_CR41","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00348-24","volume":"15","author":"JE Eschbach","year":"2024","unstructured":"Eschbach, J. E. et al. HIV-1 capsid stability and reverse transcription are finely balanced to minimize sensing of reverse transcription products via the cGAS-STING pathway. mBio 15, e0034824 (2024).","journal-title":"mBio"},{"key":"70119_CR42","doi-asserted-by":"publisher","first-page":"e1012862","DOI":"10.1371\/journal.ppat.1012862","volume":"21","author":"SW Huang","year":"2025","unstructured":"Huang, S. W. et al. The primary mechanism for highly potent inhibition of HIV-1 maturation by lenacapavir. PLoS Pathog. 21, e1012862 (2025).","journal-title":"PLoS Pathog."},{"key":"70119_CR43","doi-asserted-by":"publisher","first-page":"3536","DOI":"10.1128\/jvi.70.6.3536-3544.1996","volume":"70","author":"C Aberham","year":"1996","unstructured":"Aberham, C., Weber, S. & Phares, W. Spontaneous mutations in the human immunodeficiency virus type 1 gag gene that affect viral replication in the presence of cyclosporins. J. Virol. 70, 3536\u20133544 (1996).","journal-title":"J. Virol."},{"key":"70119_CR44","doi-asserted-by":"publisher","first-page":"9068","DOI":"10.1128\/JVI.00340-15","volume":"89","author":"J Zhou","year":"2015","unstructured":"Zhou, J., Price, A. J., Halambage, U. D., James, L. C. & Aiken, C. HIV-1 resistance to the capsid-targeting inhibitor PF74 results in altered dependence on host factors required for virus nuclear entry. J. Virol. 89, 9068\u20139079 (2015).","journal-title":"J. Virol."},{"key":"70119_CR45","doi-asserted-by":"publisher","first-page":"e1002997","DOI":"10.1371\/journal.ppat.1002997","volume":"8","author":"K Waki","year":"2012","unstructured":"Waki, K. et al. Structural and functional insights into the HIV-1 maturation inhibitor binding pocket. PLoS Pathog. 8, e1002997 (2012).","journal-title":"PLoS Pathog."},{"key":"70119_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-10-70","volume":"10","author":"H Xu","year":"2013","unstructured":"Xu, H. et al. Evidence for biphasic uncoating during HIV-1 infection from a novel imaging assay. Retrovirology 10, 70 (2013).","journal-title":"Retrovirology"},{"key":"70119_CR47","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.cell.2009.10.010","volume":"139","author":"I-JL Byeon","year":"2009","unstructured":"Byeon, I.-J. L. et al. Structural convergence between Cryo-EM and NMR reveals intersubunit interactions critical for HIV-1 capsid function. Cell 139, 780\u2013790 (2009).","journal-title":"Cell"},{"key":"70119_CR48","doi-asserted-by":"publisher","unstructured":"Siddiqui, M. A. et al. A novel phenotype links HIV-1 capsid stability to cGAS-mediated DNA sensing. J. Virol. 93, https:\/\/doi.org\/10.1128\/JVI.00706-19 (2019).","DOI":"10.1128\/JVI.00706-19"},{"key":"70119_CR49","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/nature12162","volume":"497","author":"G Zhao","year":"2013","unstructured":"Zhao, G. et al. Mature HIV-1 capsid structure by cryo-electron microscopy and all-atom molecular dynamics. Nature 497, 643\u2013646 (2013).","journal-title":"Nature"},{"key":"70119_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51971-w","volume":"15","author":"A Kleinpeter","year":"2024","unstructured":"Kleinpeter, A. et al. HIV-1 adapts to lost IP6 coordination through second-site mutations that restore conical capsid assembly. Nat. Commun. 15, 8017 (2024).","journal-title":"Nat. Commun."},{"key":"70119_CR51","doi-asserted-by":"publisher","first-page":"e1009484","DOI":"10.1371\/journal.ppat.1009484","volume":"17","author":"A Guedan","year":"2021","unstructured":"Guedan, A. et al. HIV-1 requires capsid remodelling at the nuclear pore for nuclear entry and integration. PLoS Pathog. 17, e1009484 (2021).","journal-title":"PLoS Pathog."},{"key":"70119_CR52","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.str.2019.04.015","volume":"27","author":"SS Smaga","year":"2019","unstructured":"Smaga, S. S. et al. MxB restricts HIV-1 by targeting the tri-hexamer interface of the viral capsid. Structure 27, 1234\u20131245 (2019).","journal-title":"Structure"},{"key":"70119_CR53","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2202815120","volume":"120","author":"Q Shen","year":"2023","unstructured":"Shen, Q. et al. The capsid lattice engages a bipartite NUP153 motif to mediate nuclear entry of HIV-1 cores. Proc. Natl. Acad. Sci. USA. 120, e2202815120 (2023).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"70119_CR54","first-page":"1878","volume":"39","author":"V Naik","year":"2025","unstructured":"Naik, V. et al. Emergence of in-vitro resistance to lenacapavir is similar across HIV-1 subtypes. AIDS 39, 1878\u20131886 (2025).","journal-title":"AIDS"},{"key":"70119_CR55","doi-asserted-by":"publisher","unstructured":"Sun, Q. et al. Molecular dynamics free energy simulations reveal the mechanism for the antiviral resistance of the M66I HIV-1 capsid mutation. Viruses 13, https:\/\/doi.org\/10.3390\/v13050920 (2021).","DOI":"10.3390\/v13050920"},{"key":"70119_CR56","doi-asserted-by":"publisher","first-page":"5975","DOI":"10.1002\/jmv.28064","volume":"94","author":"X Jiang","year":"2022","unstructured":"Jiang, X. et al. Discovery of novel 1,2,4-triazole phenylalanine derivatives targeting an unexplored region within the interprotomer pocket of the HIV capsid protein. J. Med. Virol. 94, 5975\u20135986 (2022).","journal-title":"J. Med. Virol."},{"key":"70119_CR57","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01694-22","volume":"67","author":"C Wang","year":"2023","unstructured":"Wang, C. et al. Antiviral properties of HIV-1 capsid inhibitor GSK878. Antimicrob. Agents Chemother. 67, e0169422 (2023).","journal-title":"Antimicrob. Agents Chemother."},{"key":"70119_CR58","doi-asserted-by":"publisher","unstructured":"Akther, T. et al. Design and synthesis of new GS-6207 subtypes for targeting HIV-1 capsid protein. Int. J. Mol. Sci. 25, https:\/\/doi.org\/10.3390\/ijms25073734 (2024).","DOI":"10.3390\/ijms25073734"},{"key":"70119_CR59","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1038\/s44321-024-00143-w","volume":"16","author":"A Boulay","year":"2024","unstructured":"Boulay, A. et al. A new class of capsid-targeting inhibitors that specifically block HIV-1 nuclear import. EMBO Mol. Med. 16, 2918\u20132945 (2024).","journal-title":"EMBO Mol. Med."},{"key":"70119_CR60","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1128\/AEM.06265-11","volume":"78","author":"Y Nov","year":"2012","unstructured":"Nov, Y. When second best is good enough: another probabilistic look at saturation mutagenesis. Appl. Environ. Microbiol. 78, 258\u2013262 (2012).","journal-title":"Appl. Environ. Microbiol."},{"key":"70119_CR61","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.cell.2014.06.022","volume":"158","author":"F Gao","year":"2014","unstructured":"Gao, F. et al. Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies. Cell 158, 481\u2013491 (2014).","journal-title":"Cell"},{"key":"70119_CR62","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1128\/AAC.46.6.1896-1905.2002","volume":"46","author":"X Wei","year":"2002","unstructured":"Wei, X. et al. Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob. Agents Chemother. 46, 1896\u20131905 (2002).","journal-title":"Antimicrob. Agents Chemother."},{"key":"70119_CR63","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.virol.2005.12.035","volume":"349","author":"V Zennou","year":"2006","unstructured":"Zennou, V. & Bieniasz, P. D. Comparative analysis of the antiretroviral activity of APOBEC3G and APOBEC3F from primates. Virology 349, 31\u201340 (2006).","journal-title":"Virology"},{"key":"70119_CR64","doi-asserted-by":"publisher","first-page":"9564","DOI":"10.1073\/pnas.91.20.9564","volume":"91","author":"JK Yee","year":"1994","unstructured":"Yee, J. K. et al. A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. Proc. Natl. Acad. Sci. USA. 91, 9564\u20139568 (1994).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"70119_CR65","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","volume":"37","author":"D Kim","year":"2019","unstructured":"Kim, D., Paggi, J. M., Park, C., Bennett, C. & Salzberg, S. L. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat. Biotechnol. 37, 907\u2013915 (2019).","journal-title":"Nat. Biotechnol."},{"key":"70119_CR66","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson, J. T. et al. Integrative genomics viewer. Nat. Biotechnol. 29, 24\u201326 (2011).","journal-title":"Nat. Biotechnol."},{"key":"70119_CR67","doi-asserted-by":"publisher","DOI":"10.1002\/pro.4792","volume":"32","author":"EC Meng","year":"2023","unstructured":"Meng, E. C. et al. UCSF ChimeraX: tools for structure building and analysis. Protein Sci. 32, e4792 (2023).","journal-title":"Protein Sci."},{"key":"70119_CR68","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754\u20131760 (2009).","journal-title":"Bioinformatics"},{"key":"70119_CR69","doi-asserted-by":"publisher","unstructured":"Danecek, P. et al. Twelve years of SAMtools and BCFtools. Gigascience 10, https:\/\/doi.org\/10.1093\/gigascience\/giab008 (2021).","DOI":"10.1093\/gigascience\/giab008"},{"key":"70119_CR70","doi-asserted-by":"publisher","first-page":"11189","DOI":"10.1093\/nar\/gks918","volume":"40","author":"A Wilm","year":"2012","unstructured":"Wilm, A. et al. LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets. Nucleic Acids Res. 40, 11189\u201311201 (2012).","journal-title":"Nucleic Acids Res."},{"key":"70119_CR71","doi-asserted-by":"publisher","first-page":"e50859","DOI":"10.1371\/journal.pone.0050859","volume":"7","author":"J Vermeire","year":"2012","unstructured":"Vermeire, J. et al. Quantification of reverse transcriptase activity by real-time PCR as a fast and accurate method for titration of HIV, lenti- and retroviral vectors. PLoS ONE 7, e50859 (2012).","journal-title":"PLoS ONE"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70119-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70119-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70119-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:03:41Z","timestamp":1776729821000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70119-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,7]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["70119"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-70119-6","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,7]]},"assertion":[{"value":"2 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3626"}}